Featured Article: Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Featured Article: Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
Authors
Keywords
-
Journal
EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 240, Issue 4, Pages 426-437
Publisher
SAGE Publications
Online
2014-10-11
DOI
10.1177/1535370214554881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
- (2015) Numsen Hail et al. NEOPLASIA
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells
- (2014) OU HUANG et al. ONCOLOGY REPORTS
- Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
- (2013) Olav Engebraaten et al. AMERICAN JOURNAL OF PATHOLOGY
- Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
- (2013) Jiwon Oh et al. CNS DRUGS
- Drugs in Development for Relapsing Multiple Sclerosis
- (2013) Rehiana Ali et al. DRUGS
- Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis
- (2013) Michael D Wiese et al. Expert Opinion on Drug Metabolism & Toxicology
- Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
- (2013) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic targets in triple negative breast cancer
- (2013) Sandra A O'Toole et al. JOURNAL OF CLINICAL PATHOLOGY
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Stromal EGF and IGF-I Together Modulate Plasticity of Disseminated Triple-Negative Breast Tumors
- (2013) Z. Castano et al. Cancer Discovery
- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- Matrix Metalloproteinase 9 (MMP-9)-dependent Processing of βig-h3 Protein Regulates Cell Migration, Invasion, and Adhesion
- (2012) Yeon Hyang Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
- (2012) Dai Horiuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synergistic Effect of Pasireotide and Teriflunomide in Carcinoids in vitro
- (2012) Yash Somnay et al. NEUROENDOCRINOLOGY
- The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
- (2012) Edmond F. O’Donnell et al. PLoS One
- Evidence supporting a role for dihydroorotate dehydrogenase, bioenergetics, and p53 in selective teriflunomide-induced apoptosis in transformed versus normal human keratinocytes
- (2011) Numsen Hail et al. APOPTOSIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Leflunomide Induces Apoptosis in Fludarabine-Resistant and Clinically Refractory CLL Cells
- (2011) S. Dietrich et al. CLINICAL CANCER RESEARCH
- Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells
- (2011) Tsung-Ying Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- DHODH modulates transcriptional elongation in the neural crest and melanoma
- (2011) Richard Mark White et al. NATURE
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Teriflunomide encourages cytostatic and apoptotic effects in premalignant and malignant cutaneous keratinocytes
- (2010) Numsen Hail et al. APOPTOSIS
- Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer
- (2010) Monika L. Burness et al. CANCER JOURNAL
- Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth
- (2010) M. R. Cook et al. MOLECULAR CANCER THERAPEUTICS
- Transcriptional role of cyclin D1 in development revealed by a genetic–proteomic screen
- (2010) Frédéric Bienvenu et al. NATURE
- Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells
- (2009) Antonello A. Romani et al. BIOCHEMICAL PHARMACOLOGY
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells
- (2009) P. Baumann et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now